Lilly (LLY) Hits Record High on Crohn's Disease Study Data [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
While management had previously reported that the study VIVID-1 study achieved its co-primary and all major secondary endpoints, the latest press release showed that mirikizumab also worked in bio-failed patients (harder-to-treat patients for whom biologics either did not or stopped working). Per Lilly, 39.3% of bio-naïve patients (those who had never tried a biologic) who received mirikizumab across a 52-week treatment period achieved an endoscopic response compared with 11.8% for those patients on placebo. With regard to bio-failed patients, 36.7% of patients on mirikizumab achieved endoscopic response compared with 6.2% on placebo. Further, 47.3% of bio-naïve and 43.4% of bio-failed patients on mirikizumab achieved clinical remission at week 52 compared with 26.5% and 12.4% of patients on placebo, respectively. Per management, the response rates and treatment effects were observed across both groups. Overall data from the study showed that 54.1% of patients treated with miri
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly unveils new manufacturing plant for GLP-1 pens [Yahoo! Finance Canada]Yahoo! Finance Canada
- Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research [Yahoo! Finance]Yahoo! Finance
- Biologics Market to Surpass USD 1125.55 Billion by 2031 | SkyQuest [Yahoo! Finance]Yahoo! Finance
- Eli Lilly doubles investment to $2 billion in Concord pharma facility ahead of opening [Yahoo! Finance]Yahoo! Finance
- Aktis Oncology Expands its Board of Directors with Appointment of Nuclear Medicine Expert Ken Herrmann, MD, MBA [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 6/14/24 - Form 144
- 6/11/24 - Form 4
- 6/10/24 - Form 4
- LLY's page on the SEC website